Abstract
The Costus plant species are found in Africa, Asia, and America. Costus genus consists of 175 species. Costus is a medicinal plant and is commonly used to treat a variety of maladies, including diabetes and its accompanying disorders. The major secondary metabolites found in costus genus include alkaloids, glycosides, flavanoids, sterols, sesquiterpenes and phenols. Considerable levels of saponins from their seeds include dioscin, diosgenin and gracillin. The plant extracts demonstrate a number of medicinal applications that include antibacterial, antioxidant, antifungal, antidiuretic, anti-inflammatory, analgesic, anti-hyperglycemic, antipyretic, estrogenic, and anti-stress activities. In this work, the medicinal applications of the plant is described on the basis of literature.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Specht, C. D., & Stevenson, D. W. (2006). A new phylogeny-based generic classification of Costaceae (Zingiberales). Taxon, 55(1), 153–163.
El-Far, A., & Abou-Ghanema, I. (2013). Biochemical and hematological evaluation of Costus speciosus as a dietary supplement to Egyptian buffaloes. African Journal of Pharmacy and Pharmacology, 7(42), 2774–2779.
Kirchoff, B. K., & Rutishauser, R. (1990). The phyllotaxy of costus (Costaceae). Botanical Gazette, 151(1), 88–105.
Ariharan, V., Devi, V. M., Rajakokhila, M., & Prasad, P. N. (2012). Antibacterial activity of Costus speciosus rhizome extract on some pathogenic bacteria. International Journal of Advanced Life Sciences, 4, 24–27.
Arunvanan, M., Sasi, S., Mubarak, H., & Kanagarajan, A. (2013). An overview on anti diabetic activity of Siddha medicinal plants. Asian Journal of Pharmaceutical and Clinical Research, 6, 46–50.
Trease, G. E. (1945). A text-book of pharmacology. Bailliere Tindall & Cassell.
Pawar, V., & Pawar, P. (2014). Costus speciosus: An important medicinal plant. International Journal of Science and Research, 3(7), 28–33.
Ekpo, B. A., Bala, D. N., Essien, E. E., & Adesanya, S. A. (2008). Ethnobotanical survey of Akwa Ibom state of Nigeria. Journal of Ethnopharmacology, 115(3), 387–408.
Edeoga, H., & Okoli, B. (1996). Apomictic behaviour in Costus afer–C. lucanusianus (Costaceae) complex in Nigeria. Feddes Repertorium, 107(1–2), 75–82.
Aweke, G. (2007). Costus afer (Ker Grawl). In G. H. Schmelzer & A. Guribraukin (Eds.), Plant Resources of Tropical Africa (PROTA).
Agbede, O. O. (2009). Understanding soil and plant nutrition. Petra Digital Press.
Smith, R., & Smith, T. (2001). Ecology and field biology (6th ed.). Benjamin Cummings. An imprint of Addison Wesley Longman.
Srivastava, S., Singh, P., Jha, K., Mishra, G., Srivastava, S., & Khosa, R. (2011). Anthelmintic activity of aerial parts of Costus speciosus. International Journal of Green Pharmacy (IJGP), 5.
Rani, A. S., Sulakshana, G., & Patnaik, S. (2012). Costus speciosus, an antidiabetic plant-review. FS Journal of Pharmacy Research, 1(3), 51–53.
Najma, C., Chandra, K., & Ansarul, H. (2012). Effect of Costus speciosus Koen on reproductive organs of female albino mice. International Research Journal of Pharmacy, 3(4), 200–202.
Kuniyal, C. P., Heinen, J. T., Negi, B. S., & Kaim, J. C. (2019). Is cultivation of Saussurea costus (Asterales: Asteraceae) sustaining its conservation? Journal of Threatened Taxa, 11(13), 14745–14752.
Kuniyal, C. P., Rawat, Y. S., Oinam, S. S., Kuniyal, J. C., & Vishvakarma, S. C. (2005). Kuth (Saussurea lappa) cultivation in the cold desert environment of the Lahaul valley, northwestern Himalaya, India: Arising threats and need to revive socio-economic values. Biodiversity and Conservation, 14(5), 1035–1045.
Atere, T., Akinloye, O., Ugbaja, R., Ojo, D., & Dealtry, G. (2018). In vitro antioxidant capacity and free radical scavenging evaluation of standardized extract of Costus afer leaf. Food Science and Human Wellness, 7(4), 266–272.
Omokhua, G. (2011). Medicinal and socio-cultural importance of Costus afer (Ker Grawl) in Nigeria. African Research Review, 5(5), 282–287.
Sarin, Y., Bedi, K., & Atal, C. (1974). Costus speciosus rhizome as source of diosgenin. Current Science, 569–570.
Whistler, W. A. (2000). Tropical ornamentals: A guide.
Sohrab, S., Mishra, P., & Mishra, S. K. (2021). Phytochemical competence and pharmacological perspectives of an endangered boon—Costus speciosus (Koen.) Sm.: A comprehensive review. Bulletin of the National Research Centre, 45(1), 1–27.
Malviya, N., Jain, S., & Malviya, S. (2010). Antidiabetic potential of medicinal plants. Acta Poloniae Pharmaceutica, 67(2), 113–118.
Bever, B. O. (1980). Oral hypoglycaemic plants in West Africa. Journal of Ethnopharmacology, 2(2), 119–127.
Urooj, A. (2010). Nutrient profile and antioxidant components of Costus speciosus Sm. and Costus igneus Nak. Indian Journal of Natural Products and Resources 11:116-118
Van Wyk, B.-E., & Wink, M. (2018). Medicinal plants of the world. Centre for Agriculture and Bioscience International.
Jayaweera, D. (1982). Medicinal plants (p. 151). National Science Council of Sri Lanka.
Bavarva, J. H., & Narasimhacharya, A. (2008). Antihyperglycemic and hypolipidemic effects of Costus speciosus in alloxan induced diabetic rats. Phytotherapy Research: An International Journal Devoted to Pharmacological and Toxicological Evaluation of Natural Product Derivatives, 22(5), 620–626.
Waisundara, V., Watawana, M., & Jayawardena, N. (2015). Costus speciosus and Coccinia grandis: Traditional medicinal remedies for diabetes. South African Journal of Botany, 98, 1–5.
Muniyandi, S., Nandanan, A., Veeti, S., Narayanan, A., & Ganesan, B. (2013). Studies on Costus speciosus Koen alcoholic extract for larvicidal activity. International Journal of Pharmacognosy and Phytochemical Research, 5(4), 328–329.
Dubey, S., Vijendra, K., Amit, K., Amit, K., & Tiwari, A. (2010). Evaluation of diuretic activity of aqueous and alcoholic rhizomes extracts of Costus speciosus Linn in wister Albino rats. International Journal of Research in Ayurveda and Pharmacy (IJRAP), 1(2), 648–652.
Rajesh, M., Harish, M., Sathyaprakash, R., Shetty, A. R., & Shivananda, T. (2009). Antihyperglycemic activity of the various extracts of Costus speciosus rhizomes. Journal of natural remedies, 9(2), 235–241.
Rastogi, R., & Mehrotra, B. (2004). Compendium of medicinal plants (p. 406). Central Drug Research Institute (CDRI)/National Institute of Communication and Information Resources.
Qiao, C.-f., Li, Q.-W., Dong, H., Xu, L.-S., & Wang, Z.-t. (2002). Studies on chemical constituents of two plants from Costus. Zhongguo Zhong yao za zhi = Zhongguo zhongyao zazhi = China Journal of Chinese Materia Medica, 27(2), 123–125.
Yan, C., You-Mei, T., Su-Lan, Y., Yu-Wei, H., Jun-Ping, K., Bao-Lin, L., et al. (2015). Advances in the pharmacological activities and mechanisms of diosgenin. Chinese Journal of Natural Medicines, 13(8), 578–587.
Eliza, J., Daisy, P., Ignacimuthu, S., & Duraipandiyan, V. (2009). Antidiabetic and antilipidemic effect of eremanthin from Costus speciosus (Koen.) Sm., in STZ-induced diabetic rats. Chemico-Biological Interactions, 182(1), 67–72.
Melchias, G. (2001). Biodiversity and conservation. Science.
Shobana, S., & Naidu, K. A. (2000). Antioxidant activity of selected Indian spices. Prostaglandins, Leukotrienes and Essential Fatty Acids (PLEFA), 62(2), 107–110.
Gupta, A. K. (2003). Quality standards of Indian medicinal plants.
Bown, D. (1995). Encyclopaedia of herbs and their uses (International Standard Book Number, 7513) (pp. 20–31). Dorling Kindersley.
Chopra, R., Nayar, S., & Chopra, I. (2006). Glossary of Indian medicinal plants, National Institute of Science Communication and Information Resources (p. 203). Council of Scientific & Industrial Research.
Sivarajan, V., & Balachandran, I. (1994). Ayurvedic drugs and their plant sources (pp. 374–376). Oxford and IBH Publishing Co. Pvt. Ltd.
Bhuyan, B., & Zaman, K. (2008). Evaluation of hepatoprotactive activity of rhizomes of Costus speciosus (J Konig) Smith. Pharmacology, 3, 119–126.
Khanna, P., Sharma, G., Rathore, A., & Manot, S. (1977). Effect of cholesterol on in vitro suspension tissue cultures of Costus speciosus (Koen) Sm., Dioscorea floribunda Mart. & Gal., Solanum aviculare Forst. & Solanum xanthocarpum Schard & Wendl. Indian Journal of Experimental Biology.
Rathore, A. K., & Khanna, P. (1978). Production of Diosgenin from Costus speciosus (Koen) Sm., and Solanum Nigrum L., suspension cultures. Current Science, 47(22), 870–871.
Rastogi, R. P., & Mehrotra, B. (1990). Compendium of Indian medicinal plants. Central Drug Research Institute.
Nadkarni, K. (2009). Indian materia medica, reprinted. Bombay Popular Prakashan, 1, 21.
Gupta, R. (2010). Medicinal and aromatic plants: Traditional and commercial uses agrotechniques biodiversity conservation. CBS Publishers & Distributors.
Malabadi, R. B. (2005). Antibacterial activity in the rhizome extract of Costus speciosus (Koen.). Journal of Phytological Research, 18(1), 83–85.
Soladoye, M., & Oyesika, O. (2008). A textbook of medicinal plants from Nigeria. University of Lagos Press.
Omukhua, G., & Godwin-Egein, M. (2011). Root rot disease of five fruit tree seedlings in the nursery. Journal of Agriculture and Social Research (JASR), 11(1).
Panagal, M., Kumar, R. A., Bastin, T. J., Jenifer, S., & Muthuvel, A. (2010). Comparative evaluation of extracts of C. igneus (or C. pictus) for hypoglycemic and hypolipidemic activity in alloxan diabetic rats. International Journal of Pharmacy and Technology, 2(1), 183–195.
Jayasri, M., MATHEWS, L. & Radha, A. (2009). A report on the antioxidant activity of leaves and rhizomes of Costus pictms.
Butola, J. S., & Samant, S. S. (2010). Saussurea species in Indian Himalayan region: Diversity, distribution and indigenous uses. International Journal of Plant Biology, 1(1), e9.
El-Far, A. H., Shaheen, H. M., Alsenosy, A. W., El-Sayed, Y. S., Jaouni, S. K., & Mousa, S. A. (2018). Costus speciosus: Traditional uses, phytochemistry, and therapeutic potentials. Pharmacognosy Reviews, 12, 120–127.
Rezaeian, S. (2011). Assessment of diosgenin production by Trigonella foenum-graecum L. in vitro condition. American Journal of Plant Physiology, 6(5), 261–268.
Lepage, C., Liagre, B., Cook-Moreau, J., Pinon, A., & Beneytout, J.-L. (2010). Cyclooxygenase-2 and 5-lipoxygenase pathways in diosgenin-induced apoptosis in HT-29 and HCT-116 colon cancer cells. International Journal of Oncology, 36(5), 1183–1191.
Attele, A. S., Wu, J. A., & Yuan, C.-S. (1999). Ginseng pharmacology: Multiple constituents and multiple actions. Biochemical Pharmacology, 58(11), 1685–1693.
Sautour, M., Mitaine-Offer, A.-C., Miyamoto, T., Dongmo, A., & Lacaille-Dubois, M.-A. (2004). Antifungal steroid saponins from Dioscorea cayenensis. Planta Medica, 70(01), 90–92.
Higdon, K., Scott, A., Tucci, M., Benghuzzi, H., Tsao, A., Puckett, A., et al. (2001). The use of estrogen, DHEA, and diosgenin in a sustained delivery setting as a novel treatment approach for osteoporosis in the ovariectomized adult rat model. Biomedical Sciences Instrumentation, 37, 281–286.
Chen, P.-S., Shih, Y.-W., Huang, H.-C., & Cheng, H.-W. (2011). Diosgenin, a steroidal saponin, inhibits migration and invasion of human prostate cancer PC-3 cells by reducing matrix metalloproteinases expression. PLoS One, 6(5), e20164.
Behera, K., Sahoo, S., & Prusti, A. (2010). Biochemical quantification of diosgenin and ascorbic acid from the tubers of different Dioscorea species found in Orissa. Libyan Agriculture Research Center Journal International, 1(2), 123–127.
McCullough, J. L., & Kelly, K. M. (2006). Prevention and treatment of skin aging. Annals of the New York Academy of Sciences, 1067(1), 323–331.
Tada, Y., Kanda, N., Haratake, A., Tobiishi, M., Uchiwa, H., & Watanabe, S. (2009). Novel effects of diosgenin on skin aging. Steroids, 74(6), 504–511.
Lee, J., Jung, K., Kim, Y. S., & Park, D. (2007). Diosgenin inhibits melanogenesis through the activation of phosphatidylinositol-3-kinase pathway (PI3K) signaling. Life Sciences, 81(3), 249–254.
Misso, M. L., Egberts, K. J., Page, M., O’Connor, D., & Shaw, J. (2010). Continuous subcutaneous insulin infusion (CSII) versus multiple insulin injections for type 1 diabetes mellitus. Cochrane Database of Systematic Reviews, 1.
Fealy, C. E., Nieuwoudt, S., Foucher, J. A., Scelsi, A. R., Malin, S. K., Pagadala, M., et al. (2018). Functional high-intensity exercise training ameliorates insulin resistance and cardiometabolic risk factors in type 2 diabetes. Experimental Physiology, 103(7), 985–994.
Castellanos, I. S., Jeremic, A., Cohen, J., & Zderic, V. (2017). Ultrasound stimulation of insulin release from pancreatic beta cells as a potential novel treatment for type 2 diabetes. Ultrasound in Medicine & Biology, 43(6), 1210–1222.
Huang, Q., Wang, L., Yu, H., & Ur-Rahman, K. (2019). Advances in phenylboronic acid-based closed-loop smart drug delivery system for diabetic therapy. Journal of Controlled Release, 305, 50–64.
Neuenschwander, M., Ballon, A., Weber, K. S., Norat, T., Aune, D., Schwingshackl, L., et al. (2019). Role of diet in type 2 diabetes incidence: Umbrella review of meta-analyses of prospective observational studies. British Medical Journal, 366.
Teng, H., & Chen, L. (2017). α-Glucosidase and α-amylase inhibitors from seed oil: A review of liposoluble substance to treat diabetes. Critical Reviews in Food Science and Nutrition, 57(16), 3438–3448.
Gan, Q., Wang, J., Hu, J., Lou, G., Xiong, H., Peng, C., et al. (2020). The role of diosgenin in diabetes and diabetic complications. The Journal of Steroid Biochemistry and Molecular Biology, 198, 105575.
Uemura, T., Goto, T., Kang, M. S., Mizoguchi, N., Hirai, S., Lee, J. Y., et al. (2011). Diosgenin, the main aglycon of fenugreek, inhibits LXRα activity in HepG2 cells and decreases plasma and hepatic triglycerides in obese diabetic mice. The Journal of Nutrition, 141(1), 17–23.
Sethi, G., Shanmugam, M. K., Warrier, S., Merarchi, M., Arfuso, F., Kumar, A. P., et al. (2018). Pro-apoptotic and anti-cancer properties of diosgenin: A comprehensive and critical review. Nutrients, 10(5), 645.
Lv, Y.-c., Yang, J., Yao, F., Xie, W., Tang, Y.-y., Ouyang, X.-p., et al. (2015). Diosgenin inhibits atherosclerosis via suppressing the MiR-19b-induced downregulation of ATP-binding cassette transporter A1. Atherosclerosis, 24(1), 80–89.
Tikhonova, M. A., Yu, C.-H., Kolosova, N. G., Gerlinskaya, L. A., Maslennikova, S. O., Yudina, A. V., et al. (2014). Comparison of behavioral and biochemical deficits in rats with hereditary defined or d-galactose-induced accelerated senescence: Evaluating the protective effects of diosgenin. Pharmacology Biochemistry and Behavior, 120, 7–16.
Kwon, C.-S., Sohn, H. Y., Kim, S. H., Kim, J. H., Son, K. H., Lee, J. S., et al. (2003). Anti-obesity effect of Dioscorea nipponica Makino with lipase-inhibitory activity in rodents. Bioscience, Biotechnology, and Biochemistry, 67(7), 1451–1456.
Siddiqui, M. A., Ali, Z., Chittiboyina, A. G., & Khan, I. A. (2018). Hepatoprotective effect of steroidal glycosides from Dioscorea villosa on hydrogen peroxide-induced hepatotoxicity in HepG2 cells. Frontiers in Pharmacology, 9, 797.
Lee, C. Y., Chou, Y. E., Hsin, M. C., Lin, C. W., Wang, P. H., Yang, S. F., et al. (2020). Dioscorea nipponica Makino suppresses TPA-induced migration and invasion through inhibition of matrix metalloproteinase-9 in human cervical cancer cells. Environmental Toxicology, 35(11), 1194–1201.
Xu, L.-N., Wei, Y.-L., & Peng, J.-Y. (2015). Advances in study of dioscin – A natural product. Zhongguo Zhong yao za zhi = Zhongguo zhongyao zazhi = China Journal of Chinese Materia Medica, 40(1), 36–41.
Bandopadhyay, S., Anand, U., Gadekar, V. S., Jha, N. K., Gupta, P. K., Behl, T., et al. (2021). Dioscin: A review on pharmacological properties and therapeutic values. BioFactors.
Balaji, M., Ganjayi, M. S., Kumar, G. E. H., Parim, B. N., Mopuri, R., & Dasari, S. (2016). A review on possible therapeutic targets to contain obesity: The role of phytochemicals. Obesity Research & Clinical Practice, 10(4), 363–380.
Fernandes, P., Cruz, A., Angelova, B., Pinheiro, H., & Cabral, J. (2003). Microbial conversion of steroid compounds: Recent developments. Enzyme and Microbial Technology, 32(6), 688–705.
Wang, Y., Zhang, Y., Zhu, Z., Zhu, S., Li, Y., Li, M., et al. (2007). Exploration of the correlation between the structure, hemolytic activity, and cytotoxicity of steroid saponins. Bioorganic & Medicinal Chemistry, 15(7), 2528–2532.
He, Z., Tian, Y., Zhang, X., Bing, B., Zhang, L., Wang, H., et al. (2012). Anti-tumour and immunomodulating activities of diosgenin, a naturally occurring steroidal saponin. Natural Product Research, 26(23), 2243–2246.
Christ, B., Xu, C., Xu, M., Li, F.-S., Wada, N., Mitchell, A. J., Han, X.-L., et al. (2019). Repeated evolution of cytochrome P450-mediated spiroketal steroid biosynthesis in plants. Nature Communications, 10(1), 1–11.
Sonawane, P. D., Pollier, J., Panda, S., Szymanski, J., Massalha, H., Yona, M., et al. (2016). Plant cholesterol biosynthetic pathway overlaps with phytosterol metabolism. Nature Plants, 3(1), 1–13.
Yang, Y., Laval, S., & Yu, B. (2014). Chemical synthesis of saponins. Advances in Carbohydrate Chemistry and Biochemistry, 71, 137–226.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2023 The Author(s), under exclusive license to Springer Nature Switzerland AG
About this chapter
Cite this chapter
Aslam, S., Ahmad, M., Shahid, S., Zahoor, A.F., AL-Huqail, A.A. (2023). Costus. In: Zia-Ul-Haq, M., Abdulkreem AL-Huqail, A., Riaz, M., Farooq Gohar, U. (eds) Essentials of Medicinal and Aromatic Crops. Springer, Cham. https://doi.org/10.1007/978-3-031-35403-8_8
Download citation
DOI: https://doi.org/10.1007/978-3-031-35403-8_8
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-031-35402-1
Online ISBN: 978-3-031-35403-8
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)